The Business of BrainHealth (Oct 13th, Washington DC): Investment, GTM, Monetization

​The Business of BrainHealth (Oct 13th, Washington DC): Investment, GTM, Monetization

​BrainHealth innovation can be difficult to scale. It scales when Founders, clinicians, investors, operators, regulators and budget owners challenge one another to think bigger, reduce friction and demonstrate substantial ROI. On Tuesday, October 13th, 5:30pm, 1700 Pennyslvania Avenue NW, Washington DC, join an information-packed session focused on investment, reimbursement and go-to-market strategies that can transform your business. If you are building, investing in, or supporting BrainHealth innovation - this is for you. Confirmed Speakers:

​Moderator: ​Moderator: Richard Hatzfeld, Co-Lead, Global Health Impact, FINN Partners

​VC Lecture:

• ​Dr. Maria Blekher, Managing Partner, Serendipity Impact VC

• ​Elena Serlin, Founder, 3L

• ​Todd Haim, Investment Dirctor, National Institute on Aging (NIA, part of NIH)

​Go-To-Market Keynote: Esther Howard, CEO, Bezyl

​Monetization Keynote: David Farber, FDA and Life Sciences Reimbursement Partner, King & Spalding

​Don't miss this chance to meet BrainHealth investors and practitioners with proven track records of success. Light snacks and beverages provided.

​See you at "BrainHealth- Investment, GTM, Monetization", Tuesday, October 13th, 5:30pm, King & Spalding, 1700 Pennsylvania Avenue NW, Suite 900. Please bring ID for security check-in.